Immuneering Corporation
IMRX
$1.54
$0.096.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.65% | -23.66% | -3.68% | 1.59% | 5.14% |
| Total Depreciation and Amortization | -0.86% | -3.01% | -1.53% | 0.31% | 0.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.13% | 4.09% | -2.60% | 23.40% | 5.70% |
| Change in Net Operating Assets | -153.35% | 357.27% | -190.77% | 126.99% | -242.49% |
| Cash from Operations | 2.96% | -7.71% | -16.88% | 25.60% | -31.56% |
| Capital Expenditure | 5.32% | -77.36% | 83.84% | 12.53% | 78.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 201.66% | -208.20% | -76.67% | 548.65% |
| Cash from Investing | -100.16% | 201.39% | -209.02% | -76.78% | 582.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15,884.49% | -98.02% | -- | -100.00% | 12,462.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33,784.39% | -100.94% | -- | -100.00% | 12,462.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.92% | 37.61% | -121.43% | -195.31% | 179.70% |